We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Common Contracts

4 similar Securities Purchase Agreement contracts by Alpha Teknova, Inc., Ancora Advisors, LLC, Catalyst Pharmaceutical Partners, Inc., Regenerx Biopharmaceuticals Inc

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • September 19th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • California

This Securities Purchase Agreement (this “Agreement”) is dated as of September 15, 2023, between Alpha Teknova, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

Standard Contracts

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 19th, 2021 • Ancora Advisors, LLC • Retail-eating places • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of February 9, 2021, between Potbelly Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • October 2nd, 2009 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of October 1, 2009, between Catalyst Pharmaceutical Partners, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • December 18th, 2006 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of December 15, 2006, by and among RegeneRx Biopharmaceuticals, Inc, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).